Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation

被引：2
|
作者：
Castagna, L. [1 ]
Sarina, B. [1 ,8 ]
Crocchiolo, R. [1 ,4 ]
Bramanti, S. [4 ,5 ,7 ]
Furst, S. [3 ,4 ,6 ,8 ]
Devillier, R. [2 ,4 ,5 ,7 ]
Coso, D. [2 ,9 ]
Bouabdallah, R. [3 ,5 ]
Mokart, D. [6 ,8 ]
Morabito, L. [6 ]
Harbi, S. [2 ,8 ,9 ]
Giordano, L. [7 ]
Rimondo, A.
Weiller, P. Jean
Carlo-Stella, C. [9 ]
Santoro, A. [3 ]
Chabannon, C.
Blaise, D.
机构：
[1] Dept Hematol, Transplantat Program, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy
[2] Dept Hematol, Lymphoma Program, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy
[3] Inst Paoli Calmettes, Intens Care Unit, Marseille, France
[4] Biostatist Unit, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy
[5] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy
[6] Humanitas Univ, Rozzano, Italy
[7] Inst Paoli Calmettes, Cell Therapy Unit, Marseille, France
[8] Aix Marseille Univ, Marseille, France
[9] Aix Marseille Univ, Inst Paoli Calmettes, Ctr Rech Cancerol Marseille, INSERM, Marseille, France
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷 / 12期
关键词：
BRENTUXIMAB VEDOTIN;
D O I：
10.1038/bmt.2016.257
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1644 / 1646
页数：3
相关论文
共 50 条
  • [41] Nivolumab in a patient with refractory Hodgkin's lymphoma after allogeneic stem cell transplantation
    Angenendt, L.
    Schliemann, C.
    Lutz, M.
    Rebber, E.
    Schulze, A. B.
    Weckesser, M.
    Stegger, L.
    Schaefers, M.
    Groth, C.
    Kessler, T.
    Lenz, G.
    Stelljes, M.
    Berdel, W. E.
    BONE MARROW TRANSPLANTATION, 2016, 51 (03) : 443 - 445
  • [42] Nivolumab salvage therapy before or after allogeneic stem cell transplantation in Hodgkin lymphoma
    J El Cheikh
    R Massoud
    I Abudalle
    B Haffar
    R Mahfouz
    M A Kharfan-Dabaja
    T Jisr
    A Mougharbel
    A Ibrahim
    A Bazarbachi
    Bone Marrow Transplantation, 2017, 52 : 1074 - 1077
  • [43] Nivolumab in a patient with refractory Hodgkin’s lymphoma after allogeneic stem cell transplantation
    L Angenendt
    C Schliemann
    M Lutz
    E Rebber
    A B Schulze
    M Weckesser
    L Stegger
    M Schäfers
    C Groth
    T Kessler
    G Lenz
    M Stelljes
    W E Berdel
    Bone Marrow Transplantation, 2016, 51 : 443 - 445
  • [44] Approaches to relapse after allogeneic stem cell transplantation
    Kroeger, Nicolaus
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (02) : 203 - 208
  • [45] Allogeneic stem cell transplantation in refractory Hodgkin's lymphoma after CR with Nivolumab
    Fellas, G.
    Kiehl, M.
    Hopfer, O.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 74 - 74
  • [46] Extramedullary relapse after allogeneic stem cell transplantation
    Baslar, Z
    Öngören, S
    Soysal, T
    Ferhanoglu, B
    Aktuglu, G
    Ülkii, B
    BONE MARROW TRANSPLANTATION, 1999, 23 : S2 - S2
  • [47] Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplant
    von Tresckow, Bastian
    Mueller, Horst
    Eichenauer, Dennis A.
    Glossmann, Jan P.
    Josting, Andreas
    Boell, Boris
    Klimm, Beate
    Sasse, Stephanie
    Fuchs, Michael
    Borchmann, Peter
    Engert, Andreas
    LEUKEMIA & LYMPHOMA, 2014, 55 (08) : 1922 - 1924
  • [48] Prognostic factors and long-term outcome for patients with Hodgkin's lymphoma who relapse after an autologous stem cell transplantation.
    Constans, M
    Sureda, A
    Arranz, R
    Caballero, MD
    Lahuerta, JJ
    Hernandez-Boluda, JC
    Vidal, MJ
    Garcia-Laraña, J
    Rifon, J
    Ribera, JM
    Fernandez-Abellan, P
    Moraleda, JM
    Bernal, MT
    Mateos, MV
    Martin-Mateos, M
    Cordoba, R
    Garcia-Conde, J
    Sierra, J
    Conde, E
    BLOOD, 2004, 104 (11) : 458A - 459A
  • [49] Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation
    Shah, Nirali N.
    Borowitz, Michael J.
    Robey, Nancy
    Gamper, Christopher
    Symons, Heather J.
    Loeb, David
    Wayne, Alan S.
    Chen, Allen R.
    BLOOD, 2012, 120 (21)
  • [50] BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective
    Cooney, JP
    Stiff, PJ
    Toor, AA
    Parthasarathy, M
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (03) : 177 - 182
12345